Discovery of Next Generation C5aR1 Antagonists for Peripheral and CNS Indications: Enhancing Target Coverage While Reducing Safety Liabilities

Time: 11:30 am
day: Conference Day Two

Speakers:

Kevin Hunt
Kevin Hunt